B2M and non-small cell lung carcinoma: The alteration in the B2-GM gene (B2M) leads to a reduction in MHC I on the cell surface that, in turn, prevents effective recognition by cytotoxic T lymphocytes, contributing to immune evasion in NSCLC [40,41].